Rare / Orphan, Oncology
Engineering Chimeric Antigen Receptors Fused to a High-Efficiency Lenalidomide-Degradable Tag to Control CAR-T Cell Activity - iTAG3
2024 Oxford-Harrington Rare Disease Scholar
Full profile coming soon.
Become a part of our community and receive periodic communications with news and updates, as well as notifications of grant funding opportunities.